Abstract
In previous studies, we observed that normal mice transferred with 5×106 splenocytes from diabetic mice by multiple low dose of streptozotocin-(Model 1, Ml)-showed anti-beta cell immune aggression(Im. Aggr.)at 7 and 15 days after cell injection and inhibition of both phases of glucose-stimulated insulin sccretion(I.S. × gl.) only at day 15. On the other hand, mice transferred with 2×106, 2×106 and splenocytes every 48hs-Modol 2(M2)-showed Im.Aggr. at 7 and 15 days after transfer, but no alteration of the I.S.× gl. even 40 days after cell injection. In the present report we studied if Im. Aggr. modulation in M2 could induce alterations in the I.S × gl. Anti-beta cell Im.Aggr. was evaluated by the glucose theophylline stimulated I.S. from dispersed rat islet cells. A single dose of 40mg streptozotocin injected 15 days before(M3) or after (M4) the splenocytes transfer, increased, in the receptor mice, the anti-beta cell Im.Aggr. (p 0.01) only when injected 15 days before, but induced inhibition of the first phase I.S.× 1g (p 0.05), in both cases, at day 15 post-transfer. The injection of 5×106 diabetic splenocytes(M1), 15 days after M3 transfer, increased the Im.Aggr. (p 0.01) but not the inhibition of I.S.× gl. The modulation of Im.Aggr. intensity and frequency seems to be a main factor in the beta cell function observed in the receptor mice.
Article PDF
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
de Bruno, F., Osinde, E., Venturino, C. et al. ANTI-BELL IMMUNE MODULATION AND INSULIN SECRETION IN A MODEL OF EXPERIMENTAL DIABETES OBTAINED BY PASSIVE TRANSFER OF “DIABETIC SPLENOCYTES”. Pediatr Res 28, 423 (1990). https://doi.org/10.1203/00006450-199010000-00049
Issue Date:
DOI: https://doi.org/10.1203/00006450-199010000-00049